State Action
CCAGW Urges Support for Deregulation Legislation in Ohio
CCAGW urges members of the House State and Local Government Committee to vote for legislation that would eliminate regulatory barriers for healthcare, education, and businesses to recover from the COVID-19 pandemic.
Minnesota - Oppose SF 1098
CCAGW urges the Minnesota House Minority Leader and his colleagues to oppose SF 1098, the Prescription Drug Transparency Act.
Minnesota - Oppose SF 1098
CCAGW urges Minnesota State legislators to oppose SF 1098, the Prescription Drug Transparency Act.
Minnesota - Oppose SF 1098
CCAGW urges Minnesota state senators to oppose SF 1098, the Prescription Drug Price Transparency Act.
Coalition to Maryland Gov. Hogan - Veto HB 732
April 13, 2020 The Honorable Larry Hogan Governor 100 State Circle Annapolis, Maryland 21301 Dear Governor Hogan:
Minnesota - Oppose SF 3120
CCAGW urges Minnesota State senators to oppose SF 3120, the Prescription Drug Affordability Act.
MInnesota - Oppose SF 1098
CCAGW urges Minnesota State Senate Finance Committee members to oppose SF 1098, the Prescription Drug Price Transparency Act.
Washington - Oppose SB 6088
Washington Representatives are asked to oppose SB 6088, price control and healthcare rationing legislation.
MInnesota - Oppose SF 1098
CCAGW urges Minnesota senators to oppose SF 1098, the Prescription Drug Price Transparency Act.
Washington - Oppose SB 6088
CCAGW urges Washington State senators to oppose SB 6088, Establishing a Prescription Drug Affordability Board Act.
Colorado - Oppose SB20-119
CCAGW urges Colorado State senators to oppose SB20-119, which would expand international drug importation beyond Canada.
Michigan - Oppose SB 596, SB 597, SB 598
CCAGW urges Michigan State senators to oppose legislation that would impose more restrictive requirements to the detriment of the state’s energy market.
